Identification of Risk Factors in Hypertensive Patients: Contribution of Randomized Controlled Trials Through an Individual Patient Database
Open accessAbstract
BACKGROUND: Predicting individual risk is needed to target preventive interventions toward people with the highest probability of benefit over a given time period. We assessed which prognostic factors should be used in predicting risk for hypertensive patients and in searching for treatment modifiers. METHODS AND RESULTS: Data from 24 390 hypertensive participants who constituted the control groups from 8 controlled trials (1726 deaths over 5 years) were analyzed in multivariate survival models. Outcomes were coronary heart disease death, stroke death, and cardiovascular death. We explored systematically the heterogeneity of results between trials. Left ventricular hypertrophy was electrocardiographically confirmed to be a powerful risk factor and should be included in risk scoring. Height, glomerular filtration rate, and serum uric acid deserve further exploration. Body mass index and heart rate were not confirmed as independent cardiovascular risk factors in this population. The association between male sex and coronary heart disease death was significantly stronger in British cohorts. The lack of prognostic value of diastolic blood pressure was explained by an interaction with age, with a positive association before 65 years and a negative association thereafter. Previous antihypertensive treatment was a significant risk factor. CONCLUSIONS: Clinical trials provide valuable information for risk prediction. Carefully exploring the heterogeneity among trials is a way to assess the generalizability of findings. This approach, if systematically performed, should increase the ability to identify risk modifiers and to predict individual therapeutic benefit.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In patients with hypertension, the occurrence of LVH has been associated with an increase in mortality from all cardiovascular causes.
“In patients with hypertension, the occurrence of left ventricular hypertrophy (LVH) has been associated with an increase in mortality from all cardiovascular causes (1–4).”
From Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive (2001) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793 · see citing works
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000180580 · Cited by 15,291 · see citing works
Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial Fibrillation
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,066 · see citing works
Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
Dahlöf, B., Hansson, L., Lindholm, L. H., Scherstén, B., Ekbom, T., & Wester, P.-O. (1991) · The Lancet · doi:10.1016/0140-6736(91)92589-t · Cited by 1,877 · see citing works
Multiple Risk Factor Intervention Trial
Michel, D. (1982) · JAMA · doi:10.1001/jama.1982.03330120023025 · Cited by 1,731 · see citing works
Amery, A. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91783-0 · Cited by 1,484 · see citing works
A Prospective Study of Obesity and Risk of Coronary Heart Disease in Women
Manson, J. E., Colditz, G. A., Stampfer, M. J., Willett, W. C., ROSNER, B. A., Monson, R. R., Speizer, F. E., & Hennekens, C. H. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003293221303 · Cited by 1,403 · see citing works
Medical Research Council trial of treatment of hypertension in older adults: principal results.
Peart, S., Brennan, P. J., Broughton, P., Dollery, C. T., Hudson, M. F., Lever, A. F., Meade, T. W., Rose, G., & Pocock, S. (1992) · Cited by 1,360 · see citing works
British Medical Journal Publishing Group (1992) · BMJ · doi:10.1136/bmj.304.6824.405 · Cited by 1,343 · see citing works
The Pooling Project Research Group (1978) · Journal of Chronic Diseases · doi:10.1016/0021-9681(78)90073-5 · Cited by 994 · see citing works
Rimm, E. B., Stampfer, M. J., Giovannucci, E. L., Ascherio, A., Spiegelman, D. L., Colditz, G. A., & Willett, W. C. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117385 · Cited by 840 · see citing works
Randomised trial of treatment of hypertension in elderly patients in primary care.
Coope, J., & Warrender, T. S. (1986) · BMJ · doi:10.1136/bmj.293.6555.1145 · Cited by 725 · see citing works
Cardiovascular disease after renal transplantation.
Kasiske, B. L., Guijarro, C., Massy, Z. A., Wiederkehr, M. R., & Ma, J. Z. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v71158 · Cited by 667 · see citing works
The Australian therapeutic trial in mild hypertension.
Abernethy, J. D. (1984) · Hypertension · doi:10.1161/01.hyp.6.5.774 · Cited by 518 · see citing works
An evidence based approach to individualising treatment
Glasziou, P., & Irwig, L. (1995) · BMJ · doi:10.1136/bmj.311.7016.1356 · Cited by 389 · see citing works
Management of raised blood pressure in New Zealand: a discussion document.
Jackson, R., Barham, P., Bills, J., Birch, T. B., McLennan, L., MacMahon, S. W., & Tj, M. (1993) · BMJ · doi:10.1136/bmj.307.6896.107 · Cited by 262 · see citing works
THE AUSTRALIAN THERAPEUTIC TRIAL IN MILD HYPERTENSION
(1980) · The Lancet · doi:10.1016/s0140-6736(80)91730-4 · Cited by 215 · see citing works
Height and incidence of cardiovascular disease in male physicians.
Hebert, P. R., Rich-Edwards, J. W., Manson, J. E., Ridker, P. M., Cook, N. R., O'Connor, G. T., Buring, J. E., & Hennekens, C. H. (1993) · Circulation · doi:10.1161/01.cir.88.4.1437 · Cited by 202 · see citing works
Stratifying the patient at risk from coronary disease: New insights from the framingham heart study
Levy, D. A., Wilson, P. W. F., Anderson, K. M., & Castelli, W. P. (1990) · American Heart Journal · doi:10.1016/s0002-8703(05)80050-x · Cited by 157 · see citing works
Risk factors for death from different types of stroke
Neaton, J. D., Wentworth, D. N., Cutler, J. A., Stamler, J., & Kuller, L. H. (1993) · Annals of Epidemiology · doi:10.1016/1047-2797(93)90103-b · Cited by 142 · see citing works
Height and the Risk of Cardiovascular Disease in Women
Rich-Edwards, J. W., Manson, J. E., Stampfer, M. J., Colditz, G. A., Willett, W. C., ROSNER, B. A., Speizer, F. E., & Hennekens, C. H. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117738 · Cited by 139 · see citing works
Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study.
Perry, H. M., Smith, W. M., McDonald, R. H., Black, D. M., Cutler, J. A., Furberg, C. D., Greenlick, M. R., Kuller, L. H., Schnaper, H. W., & Schoenberger, J. A. (1989) · Stroke · doi:10.1161/01.str.20.1.4 · Cited by 129 · see citing works
Alderman, M. H. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-4-199308150-00013 · Cited by 122 · see citing works
Levy, D. A. (1988) · Drugs · doi:10.2165/00003495-198800355-00002 · Cited by 116 · see citing works
Short stature and risk for mortality and cardiovascular disease events. The Framingham Heart Study.
Kannam, J. P., Levy, D. A., Larson, M. G., & Wilson, P. W. (1994) · Circulation · doi:10.1161/01.cir.90.5.2241 · Cited by 107 · see citing works
Menotti, A., Keys, A. B., Blackburn, H., Kromhout, D., Karvonen, M. J., Nissinen, A. M., Pekkanen, J., Punsar, S., Fidanza, F., Giampaoli, S., et al. (1996) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679600300110 · Cited by 105 · see citing works
Black, H. R., Boissel, J., Brenner, B. M., Brown, M., Bulpitt, C. J., Chalmers, J. P., Collins, R. D., Cutler, J. A., Dahlöf, B., Davis, B. R., et al. (1998) · Journal of Hypertension · Cited by 99 · see citing works
EVALUATION OF DRUG TREATMENT IN MILD HYPERTENSION: VA‐NHLBI FEASIBILITY TRIAL*
Neurath, H. M., Goldman, A. I., Lavin, M. A., Schnaper, H. W., Fitz, A. E., Frohlich, E. D., Steele, B. W., & Richman, H. G. (1978) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1978.tb25604.x · Cited by 91 · see citing works
Gueyffier, F., Boutitie, F., Boissel, J., Coope, J., Cutler, J., Ekbom, T., Fagard, R., Friedman, L., Perry, H. M., & Pocock, S. (1995) · PubMed · Cited by 69 · see citing works
An Effect Model for the Assessment of Drug Benefit
Boissel, J., Collet, J., Lièvre, M. M., & Girard, P. (1993) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199309000-00003 · Cited by 59 · see citing works
Flagged first, then by citations
1 of the 34 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Jackson R, Barham P, Bills T, Birch T, McLennan L, MacMahon S, Maling T. The management of raised blood pressure in New Zealand. Br Med J. 1993;307:107-110.
- Cornu C, on behalf of the TAS-PP Group. Thrombolysis in acute stroke pooling project (TAS-PP): a prospective pooled individual patient database. Control Clin Trials. 1994;15:99S. Abstract.
Cited by
Sorted by citations
Laurent, S., Boutouyrie, P., Asmar, R., Gautier, I., Laloux, B., Guize, L., Ducimetiere, P., & Benetos, A. (2001) · Hypertension · doi:10.1161/01.hyp.37.5.1236 · Cited by 3,856 · see citing works
Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study
Verdecchia, P., Carini, G., Circo, A., Dovellini, E. V., Giovannini, E., Lombardo, M., Solinas, P., Gorini, M., & Maggioni, A. P. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01663-1 · Cited by 381 · see citing works
Arterial Stiffness and Stroke in Hypertension
Laurent, S., & Boutouyrie, P. (2005) · CNS Drugs · doi:10.2165/00023210-200519010-00001 · Cited by 236 · see citing works
Serum Uric Acid and Target Organ Damage in Primary Hypertension
Viazzi, F. C., Parodi, D., Leoncini, G., Parodi, A., Falqui, V., Ratto, E., Vettoretti, S., Bezante, G. P., Sette, M. D., Deferrari, G., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000161184.10873.ea · Cited by 175 · see citing works
Schillaci, G., Reboldi, G., & Verdecchia, P. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.6.886 · Cited by 175 · see citing works
Zanchetti, A., Hansson, L., Dahlöf, B., Elmfeldt, D., Kjeldsen, S. E., Kolloch, R. E., Larochelle, P. M., McInnes, G. T., Mallion, J.-M., Ruilope, L. M., et al. (2001) · Journal of Hypertension · doi:10.1097/00004872-200106000-00021 · Cited by 165 · see citing works
Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive
Greenwood, J. P., Scott, E. M., Stoker, J. B., & Mary, D. A. S. G. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01600-x · Cited by 161 · see citing works
Individual patient data meta-analysis of survival data using Poisson regression models
Crowther, M. J., Riley, R. D., Staessen, J. A., Wang, J., Gueyffier, F., & Lambert, P. C. (2012) · BMC Medical Research Methodology · doi:10.1186/1471-2288-12-34 · Cited by 102 · see citing works
Fagard, R. H., Staessen, J. A., Thijs, L., Celis, H., Birkenhäger, W. H., Bulpitt, C. J., de Leeuw, P. W., Leonetti, G., Sarti, C., Tuomilehto, J. O., et al. (2004) · Hypertension · doi:10.1161/01.hyp.0000142169.17298.54 · Cited by 69 · see citing works
Grady, D., Chaput, L. A., & Kristof, M. (2003) · PubMed Central · Cited by 50 · see citing works
Bursztyn, M., Motro, M., Grossman, E., & Shemesh, J. (2003) · Journal of Hypertension · doi:10.1097/00004872-200310000-00024 · Cited by 50 · see citing works
Huang, S., Xu, Y., Li, Y., Wei, S., Liu, L., Gan, X., Zhou, S., & Nie, S. (2010) · Hypertension Research · doi:10.1038/hr.2010.73 · Cited by 49 · see citing works
Holm, S. W., Cunningham, L. L., Bensadoun, E., & Madsen, M. J. (2005) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2005.09.023 · Cited by 44 · see citing works
Serum Uric Acid as a Risk Factor for Cardiovascular and Renal Disease: An Old Controversy Revived
Viazzi, F. C., Leoncini, G., Ratto, E., & Pontremoli, R. (2006) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2006.04755.x · Cited by 43 · see citing works
Huang, S., Hu, X., Chen, H., Xie, D., Gan, X., Wu, Y., Nie, S., & Wu, J. (2011) · Hypertension Research · doi:10.1038/hr.2010.265 · Cited by 41 · see citing works
Management of Hypertension in the Facelift Patient: Results of a National Consensus Survey
Trussler, A. P., Hatef, D. A., & Rohrich, R. J. (2011) · Aesthetic Surgery Journal · doi:10.1177/1090820x11411292 · Cited by 29 · see citing works
Controlling hypertension from a public health perspective
Chiong, J. R. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.10.039 · Cited by 26 · see citing works
Weir, M. R., Crikelair, N., Levy, D. G., Rocha, R., Kuturu, V., & Glazer, R. D. (2007) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2007.06415.x · Cited by 26 · see citing works
Fikri‐Benbrahim, N., Faus, M. J., Martínez, F. M., Alsina, D. G.-S., & Sabater‐Hernández, D. (2012) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp110616 · Cited by 26 · see citing works
Zhang, Y., Zhang, X., Liu, L., & Zanchetti, A. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833cd338 · Cited by 21 · see citing works
Wu, C., Lin, F.-C., Chen, S., Chen, Y., Chung, W.-J., & Cheng, C. (2016) · BioMed Research International · doi:10.1155/2016/2901938 · Cited by 20 · see citing works
Salles, G. F., Deccache, W., & Cardoso, C. R. L. (2005) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001815 · Cited by 17 · see citing works
Kjeldsen, S. E., Devereux, R. B., Hille, D. A., Lyle, P. A., Dahlöf, B., Julius, S., Edelman, J. M., Snapinn, S. M., Fairé, U. D., Fyhrquist, F., et al. (2009) · Blood Pressure · doi:10.3109/08037050903460590 · Cited by 17 · see citing works
Determination of risk factors for hypertension through the classification tree method
Akdağ, B., Fenkçi, S. M., Değirmencioğlu, S., Rota, S., Sermez, Y., & Ankaralı, H. Ç. (2006) · Advances in Therapy · doi:10.1007/bf02850210 · Cited by 15 · see citing works
Risk factors for hypertension among the adult Moroccan population
Tazi, M., Khalil, S. A., Arrach, M. L., Chaouki, N., & Lahmouz, F. (2009) · Eastern Mediterranean Health Journal · doi:10.26719/2009.15.4.827 · Cited by 15 · see citing works
Nelson, M. R., Chowdhury, E., Doust, J. A., Reid, C. M., & Wing, L. M. H. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000709 · Cited by 13 · see citing works
Glazer, N. L., SMITH, N., Heckbert, S. R., Doggen, C. J. M., Lemaitre, R. N., & Psaty, B. M. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.12.015 · Cited by 10 · see citing works
The new Sheffield risk and benefit tables for the elderly
Weatherley, N., & Jackson, P. R. (2010) · QJM · doi:10.1093/qjmed/hcq167 · Cited by 8 · see citing works
Prognostic value of lipoprotein fractions in essential hypertension
Verdecchia, P., Reboldi, G., Angeli, F., Gattobigio, R., Borgioni, C., Filippucci, L., Poeta, F., & Porcellati, C. (2004) · Blood Pressure · doi:10.1080/08037050410003991 · Cited by 8 · see citing works
Vock, D. M., Helgeson, E. S., Mullan, A. F., Issa, N. S., Sanka, S., Saiki, A. C., Mathson, K., Chamberlain, A. M., Rule, A. D., & Matas, A. J. (2023) · BMC Nephrology · doi:10.1186/s12882-023-03149-7 · Cited by 6 · see citing works
Topography and severity of coronary artery disease in white-coat hypertension
Kostandonis, D., Papadopoulos, V. P., Toumanidis, S. T., Papamichael, C. M., Kanakakis, I., & Zakopoulos, N. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2007.07.005 · Cited by 6 · see citing works
Observational epidemiological studies
Gueyffier, F. (2003) · Journal of Hypertension · doi:10.1097/00004872-200304000-00004 · Cited by 6 · see citing works
Proton-Pump Inhibitors Therapy and Blood Pressure Control
Joya-Vázquez, P. P., Bacaicoa, M. A., Velasco, R., Chicón, J. L., Trejo, S. J., Carrasco, M., Robles, N. R., & Muñoz-Torrero, J. F. S. (2014) · International Journal of Pharmacological Research · doi:10.7439/ijpr.v4i3.116 · Cited by 4 · see citing works
Blood Pressure Changes After a Health Promotion Program Among Mexican Workers
Garcia‐Rojas, I. J., Omidakhsh, N., Arah, O. A., & Krause, N. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.683655 · Cited by 2 · see citing works
Τζιόμαλος, Κ., Athyros, V. G., Karagiannis, A. I., & Mikhailidis, D. P. (2012) · The Open Clinical Chemistry Journal · doi:10.2174/1874241601003010044 · Cited by 2 · see citing works
Барсуков, А. В., Владимирович, Г. Д., Зобнина, М. П., Мирохина, М. А., Дыдышко, В. Т., Vasiliev, V. N., Kitzishin, V. P., & Тишко, В. В. (2015) · Advances in Gerontology · doi:10.1134/s2079057015020022 · Cited by 2 · see citing works
Oryginalna, P., Kostka-Jeziorny, K., & Tykarski, A. (2008) · Cited by 2 · see citing works
Long-Term Outcomes for the Donor
Matas, A. J., & Ibrahim, H. N. (2007) · CRC Press eBooks · doi:10.3109/9781420019650-12 · Cited by 2 · see citing works
Childhood Hyperuricemia as Risk Factor of Hypertension in Adulthood
Ramayani, O. R. (2012) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v4i1.156 · Cited by 1 · see citing works
Is legacy a myth or a reality? We should know, and we do not
Gueyffier, F., & Cucherat, M. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000728 · Cited by 1 · see citing works
Niklas, A. A., Kolasińska–Malkowska, K., Wilkins, A., & Tykarski, A. (2009)
Hsin, I., Hsu, S., Chuang, C., Huo, T., Huang, H., Lee, F., Ho, H., Chang, S.-Y., & Lee, S. (2018) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2018.01.011
Игоревна, П. А., Геннадьевна, К. О., Линчак, Р. М., Nemirovskaya, M. M., Strokan, M. V., & Эдуардовна, Б. А. (2014) · Systemic Hypertension · doi:10.26442/sg29043
INSAF-HAS: a tool to select patients with hypertension for pharmaceutical care
Girolineto, B. M. P., de Oliveira, A. M., Gonçalves, A. M. R. F., Campos, M. S. D. A., & Pereira, L. R. L. (2019) · Einstein (São Paulo) · doi:10.31744/einstein_journal/2020ao4858 · Cited by 2 · see citing works
Long-Term Outcomes for the Donor
Matas, A. J., & Ibrahim, H. N. (2008) · CRC Press eBooks · doi:10.1201/b14357-9
On platelet biology and cardiovascular disease
van Holten, T. C. (2013) · Utrecht University Repository (Utrecht University)
- Authors
- Gueyffier, F., Boissel, J.-P., Pocock, S., Boutitie, F., Coope, J., Cutler, J., Ekbom, T., Fagard, R., Friedman, L., Kerlikowske, K., Perry, M., Prineas, R., & Schron, E.
- Affiliations
- From the Clinical Pharmacology Department (F.G., J.-P.B., F.B.), Claude Bernard University, Lyon Hospitals, Lyon, France; the National Heart, Lung, and Blood Institute (J.C., L.F., E.S.), National Institutes of Health, Bethesda, Md; the Department of Community Health Sciences (T.E.), Dalby/Lund, Sweden; Veterans Administration Medical Center (K.K.), San Francisco, Calif; the Hypertension and Cardiovascular Rehabilitation Unit (R.F.), Leuven, Belgium; Washington University School of Medicine (M.P.),...
- Lyon 1 Université (FR)
- Venue
- Circulation
- Published
- 1999-11-02
- Volume
- 100
- Issue
- 18
- Pages
- e88-94
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1967388369
- Cited by
- 46
- References
- 34
- Citations by year
- 2023: 1 · 2021: 1 · 2019: 1 · 2018: 1 · 2016: 1 · 2015: 3 · 2014: 2 · 2013: 1 · 2012: 4
- FWCI
- 0.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fondation pour la Recherche Médicale
- Hospices Civils de Lyon
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Keywords
- hypertension, cardiovascular risk factors, risk prediction, left ventricular hypertrophy, coronary heart disease mortality, stroke mortality, cardiovascular mortality, trial heterogeneity, antihypertensive therapy, diastolic blood pressure, sex differences, glomerular filtration rate, serum uric acid, body mass index, heart rate, risk scoring
- MeSH terms
- Age Factors, Aged, Cardiovascular Diseases, Coronary Disease, Female, Humans, Hypertension, Male, Prognosis, Risk Factors, Sex Factors, Multivariate Analysis, Proportional Hazards Models, Odds Ratio, Survival Analysis, Randomized Controlled Trials as Topic, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
